Cargando…

Tacrolimus for Remission Induction and Maintenance Therapy in Patients with Ulcerative Colitis: A Retrospective Evaluation Study

Background. In this retrospective study, we compared the efficacy of tacrolimus (TAC) or prednisolone (PSL) for maintenance therapy in patients with ulcerative colitis (UC) at remission. Methods. The study patients were followed up for at least one year after induction of remission with either PSL (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ito, Ayumi, Iizuka, Bunei, Omori, Teppei, Nakamura, Shinichi, Tokushige, Katsutoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4927944/ https://www.ncbi.nlm.nih.gov/pubmed/27413367 http://dx.doi.org/10.1155/2016/5956316

Ejemplares similares

Development and Improvement of Simple Colonic Mucosal Ulcer during Treatment of Severe Ulcerative Colitis with Tacrolimus
por: Ito, Ayumi, et al.
Publicado: (2017)

Relationship between the Clinical Course of Ulcerative Colitis during Pregnancy and the Outcomes of Pregnancy: A Retrospective Evaluation
por: Ito, Ayumi, et al.
Publicado: (2017)

Retrospective investigation of tacrolimus combined with an anti‐tumor necrosis factorα antibody as remission induction therapy for refractory ulcerative colitis: Efficacy, safety, and relapse rate
por: Ito, Ayumi, et al.
Publicado: (2019)

Relationship between mucosal healing by tacrolimus and relapse of refractory ulcerative colitis: a retrospective study
por: Ito, Ayumi, et al.
Publicado: (2020)

Clinical Characterization of Ulcerative Colitis in Patients with Primary Sclerosing Cholangitis
por: Murasugi, Shun, et al.
Publicado: (2020)

Efficacy of Switching to Adalimumab for Maintenance of Remission Following Induction Therapy with Tacrolimus in Patients with Ulcerative Colitis
por: Numa, Keijiro, et al.
Publicado: (2023)

The Efficacy of Medium- to Long-term Anti-TNF-α Antibody-based Maintenance Therapy in Behçet's Disease Patients with Intestinal Lesions
por: Kambayashi, Harutaka, et al.
Publicado: (2020)

A Patient with Crohn’s Disease Who Gave Birth Despite Sigmoid Volvulus, Venous Thrombosis, Nontraumatic Fracture of the Rib, and Sepsis during Pregnancy
por: Ito, Ayumi, et al.
Publicado: (2023)

Rapid Induction and Maintenance of Remission in Refractory Ulcerative Colitis with Ustekinumab
por: Chen, An-Yu, et al.
Publicado: (2019)

The efficacy of maintenance therapy after remission induction with tacrolimus in ulcerative colitis with and without previous tumor necrosis factor‐α inhibitor
por: Suzuki, Taketo, et al.
Publicado: (2019)

The earliest trough concentration predicts the dose of tacrolimus required for remission induction therapy in ulcerative colitis patients
por: Hiraoka, Sakiko, et al.
Publicado: (2015)

Does the PillCam SB3 capsule endoscopy system improve image reading efficiency irrespective of experience? A pilot study
por: Omori, Teppei, et al.
Publicado: (2018)

Serum Leucine-Rich Alpha-2 Glycoprotein in Quiescent Crohn’s Disease as a Potential Surrogate Marker for Small-Bowel Ulceration detected by Capsule Endoscopy
por: Omori, Teppei, et al.
Publicado: (2022)

A Novel Capsule Endoscopic Score for Crohn’s Disease
por: Omori, Teppei, et al.
Publicado: (2020)

Successful remission of ulcerative colitis flare-up during pregnancy with adsorptive granulomonocytapheresis plus tacrolimus
por: Shibuya, Tomoyoshi, et al.
Publicado: (2018)

Ulcerative Colitis Remission Status After Induction With Mesalazine Predicts Maintenance Outcomes: the MOMENTUM Trial
por: Rubin, David T., et al.
Publicado: (2016)

Well-differentiated adenocarcinoma associated with ulcerative colitis
por: Yamamoto, Tomoko, et al.
Publicado: (2017)

Tacrolimus for the Treatment of Ulcerative Colitis
por: Matsuoka, Katsuyoshi, et al.
Publicado: (2015)

Biologic monotherapy versus combination therapy with immunomodulators in the induction and maintenance of remission of Crohn’s disease and ulcerative colitis
por: Hashash, Jana G., et al.
Publicado: (2021)

Intravenous tacrolimus is a superior induction therapy for acute severe ulcerative colitis compared to oral tacrolimus
por: Shimizu, Hiromichi, et al.
Publicado: (2021)

Cytapheresis re-induces high-rate steroid-free remission in patients with steroid-dependent and steroid-refractory ulcerative colitis
por: Iizuka, Masahiro, et al.
Publicado: (2021)

Potential benefits of immunomodulator use with vedolizumab for maintenance of remission in ulcerative colitis
por: Naganuma, Makoto, et al.
Publicado: (2021)

Granulocyte and monocyte apheresis therapy for patients with active ulcerative colitis associated with COVID-19: a case report
por: Koroku, Miki, et al.
Publicado: (2022)

Induction of remission with tacrolimus in a patient with severe acute, cortisone refractory ulcerative colitis and severe Covid-19 pneumonia: a case report
por: Rieker, Lisanne, et al.
Publicado: (2022)

Tofacitinib for induction of remission in ulcerative colitis: systematic review and meta-analysis
por: Paschos, Paschalis, et al.
Publicado: (2018)

Long-lasting renal dysfunction following tacrolimus induction therapy in ulcerative colitis patients
por: Cha, Na, et al.
Publicado: (2022)

Early serum albumin changes in patients with ulcerative colitis treated with tacrolimus will predict clinical outcome
por: Ishida, Natsuki, et al.
Publicado: (2021)

Randomised trial of once- or twice-daily MMX mesalazine for maintenance of remission in ulcerative colitis
por: Kamm, M A, et al.
Publicado: (2008)

Real-World Long-Term Remission Maintenance for 10 Years With Thiopurines in Ulcerative Colitis
por: Matsumoto, Satohiro, et al.
Publicado: (2021)

Pretreatment neutrophil-to-lymphocyte ratio predicts clinical relapse of ulcerative colitis after tacrolimus induction
por: Nishida, Yu, et al.
Publicado: (2019)

Risk Factors for Nephrotoxicity due to Tacrolimus Therapy for Ulcerative Colitis
por: Nakata, Satoshi, et al.
Publicado: (2022)

Rapid Induction Therapy with Oral Tacrolimus in Elderly Patients with Refractory Ulcerative Colitis Can Easily Lead to Elevated Tacrolimus Concentrations in Blood: A Report of 5 Cases
por: Kawamura, Haruna, et al.
Publicado: (2017)

The Influence of Obesity on Small Bowel Capsule Endoscopy
por: Omori, Teppei, et al.
Publicado: (2022)

Influence of dietary isoflavone intake on gastrointestinal symptoms in ulcerative colitis individuals in remission
por: Głąbska, Dominika, et al.
Publicado: (2017)

Fecal microbiota transplantation versus glucocorticoids for the induction of remission in mild to moderate ulcerative colitis
por: Huang, Chunlan, et al.
Publicado: (2022)

Fecal microbiota transplantation for the maintenance of remission in patients with ulcerative colitis: A randomized controlled trial
por: Lahtinen, Perttu, et al.
Publicado: (2023)

Relationship between endoscopic mucosal healing and histologic inflammation during remission maintenance phase in ulcerative colitis: a retrospective study
por: Kanazawa, Mimari, et al.
Publicado: (2019)

Colon Mucosa Exhibits Loss of Ectopic MUC5AC Expression in Patients with Ulcerative Colitis Treated with Oral Tacrolimus
por: Mizoshita, Tsutomu, et al.
Publicado: (2013)

Tacrolimus Therapy for Ulcerative Colitis-Associated Post-Colectomy Enteritis
por: Rush, Barret, et al.
Publicado: (2014)

Tacrolimus in pediatric ulcerative colitis: does it have a role?
por: Kim, Seung
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_s4gpiga8uurvuqcmvq9ktgjh0p